VanEck Biotech ETF · $519M$12,871
BBHBBH vsSCHDSCHDSchwab U.S. Dividend Equity ETF · $120B$16,375
$10,000 five years ago, dividends reinvested · they hold 4.2% in common
BBHMeasureSCHD
Returns · dividends reinvested
+32.6%Year to dateJan 1 → Nov 5+32.3%
+41.2%1 yearTotal return+38.7%
+20.9%3 years · per year$10,000 became $17,689 · $17,414+20.3%
+5.2%5 years · per year$10,000 became $12,871 · $16,375+10.4%
Cost and income
0.35%Expense ratio$35 · $6 a year on $10k · lower is better0.06%
0.38%Trailing 12-mo yield$38 · $298 a year on $10k2.98%
Risk · past year
−10.5%Worst dropSmaller is better−6.9%
22.8%VolatilityLower is calmer11.7%
BBHSCHD Winner of the row, in its colourEach row: the bigger of the two fills its side
3–5SCHD wins
End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns